Product Name | Latanoprost | |
CAS NO | 130209-82-4 | |
Appearance | White powder | |
MF | C26H40O5 | |
MW | 432.59 | |
Usage | Treatment for high intraocular pressure, glaucoma, and symptoms of various kinds of elevated intraocular pressure | |
Purity | 98% | |
Origin | China | |
Export market | Global | |
Grade | Pharmaceutical grade | |
Supply capacity | Mass in stock | |
Packing | Well disguised package to pass the customs | |
Payment | Western Union, Money Gram, Bank Transfer | |
Shipping | EMS,HKEMS,FEDEX,DHL,TNT,Aramex,etc | |
Leading time | Within 24 hours after payment. | |
Delivery time | 3-7 work days | |
99% passing rate & 100% free resend policy |
Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye. This includes ocular hypertension and open angle glaucoma.It is applied as eye drops to the eyes. Onset of effects is usually within four hours, and they last for up to a day.
Common side effects include blurry vision, redness of the eye, itchiness, and darkening of the iris. Latanoprost is in the prostaglandin analogue family of medication. It works by increasing the outflow of aqueous fluid from the eyes through the uveoscleral tract.
Latanoprost approved for medical use in the United States in 1996. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Latanoprost is available as a generic medication.
In people with ocular hypertension including open-angle glaucoma (IOP ≥21 mm Hg), treatment with latanoprost reduced IOP levels by 22 to 39% over 1 to 12 months’ treatment. Latanoprost was more effective than timolol 0.5% twice daily in 3 of 4 large (n = 163 to 267) randomised, double-blind trials. Latanoprost demonstrated a stable long-term IOP-lowering effect in 1- or 2-year continuations of these trials, with no sign of diminishing effect during prolonged treatment.